ArticleCancers2025

Clinical and Molecular Differences Suggest Different Responses to Immune Checkpoint Inhibitors in Microsatellite-Stable Solid Tumors with High Tumor Mutational Burden.

Imran Nizamuddin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.